Literature DB >> 2874767

Discontinuous transcription and antigenic variation in trypanosomes.

P Borst.   

Abstract

The main theme of this review is the discontinuous synthesis of mRNAs in trypanosomes. This novel process was discovered in the unicellular eukaryote Trypanosoma brucei, but it is probably a general feature of the order of Kinetoplastida, to which several other major human pathogens belong. Discontinuous RNA synthesis involves a sequence of 35 nucleotides (nt) found at the 5' end of all trypanosome mRNAs analyzed. The 35-nt sequence is encoded in arrays of 1.35-kb repeats that are clustered in the genome. The primary transcript of the 1.35-kb repeat is an RNA of 140 nt that carries the 35-nt sequence at its 5' end. The 35-nt sequence is transferred from the 140-nt precursor to pre-mRNAs made elsewhere in the genome. The process has not yet been reconstructed in vitro, and whether transfer involves priming of pre-mRNA synthesis, RNA-RNA ligation followed by splicing, trans-splicing, or more than one of these mechanisms, is still unknown. Circumstantial evidence makes priming the least likely of these alternatives. Why it is advantageous to trypanosomes to make their mRNAs in such an unusual fashion is unclear. As yet, there is no evidence for discontinuous synthesis of mRNAs in organisms other than kinetoplastid flagellates. The mini-exon sequence was first found in mRNAs for Variant-specific Surface Glycoproteins (VSGs), and the control of the synthesis of these proteins is a second theme of this review. Silent VSG genes may be activated by their duplicative transposition to a telomeric expression site. The transposition process looks like a gene conversion, mediated by short blocks of sequence homology. Activation of the transposed gene is due to its insertion into an active transcription unit, i.e. to promoter addition. Telomeric VSG genes can also be activated without duplication. This can occur by a reciprocal translocation in which a silent telomeric gene exchanges position with a gene residing in an active expression site. A VSG gene may also be activated without detectable translocation, however, by the transcriptional activation of the silent expression site in which it is located. How this occurs is still unknown, because the transcription units are so long that the promoter for pre-mRNA synthesis has not yet been reached by chromosome walking. A simple mechanism in which a mobile promoter moves between telomeres has been rendered unlikely by the demonstration that two telomeric transcription units can be simultaneously active when one of them is interrupted by a large DNA insertion.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874767     DOI: 10.1146/annurev.bi.55.070186.003413

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  144 in total

1.  Identification of a developmentally regulated iron superoxide dismutase of Trypanosoma brucei.

Authors:  M Kabiri; D Steverding
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

2.  Genomic organisation and expression of a differentially-regulated gene family from Leishmania major.

Authors:  H M Flinn; D F Smith
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

3.  Nuclease mapping and DNA sequence analysis of transcripts from the dihydrofolate reductase-thymidylate synthase (R) region of Leishmania major.

Authors:  G M Kapler; K Zhang; S M Beverley
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

4.  Chromosome structure: DNA nucleotide sequence elements of a subset of the minichromosomes of the protozoan Trypanosoma brucei.

Authors:  M Weiden; Y N Osheim; A L Beyer; L H Van der Ploeg
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  Stable integrative transformation of Trypanosoma brucei that occurs exclusively by homologous recombination.

Authors:  J Eid; B Sollner-Webb
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

6.  Molecular characterization, expression, and in vivo analysis of LmexCht1: the chitinase of the human pathogen, Leishmania mexicana.

Authors:  Manju B Joshi; Matthew E Rogers; Alison M Shakarian; Mat Yamage; Saeed A Al-Harthi; Paul A Bates; Dennis M Dwyer
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

7.  The promoter for the procyclic acidic repetitive protein (PARP) genes of Trypanosoma brucei shares features with RNA polymerase I promoters.

Authors:  S D Brown; J Huang; L H Van der Ploeg
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

8.  A unique, highly conserved secretory invertase is differentially expressed by promastigote developmental forms of all species of the human pathogen, Leishmania.

Authors:  Todd A Lyda; Manju B Joshi; John F Andersen; Andrew Y Kelada; Joshua P Owings; Paul A Bates; Dennis M Dwyer
Journal:  Mol Cell Biochem       Date:  2015-03-13       Impact factor: 3.396

9.  A novel class of developmentally regulated noncoding RNAs in Leishmania.

Authors:  Carole Dumas; Conan Chow; Michaela Müller; Barbara Papadopoulou
Journal:  Eukaryot Cell       Date:  2006-10-27

10.  Disruption of largest subunit RNA polymerase II genes in Trypanosoma brucei.

Authors:  H M Chung; M G Lee; P Dietrich; J Huang; L H Van der Ploeg
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.